Open Science Research Excellence

ICCDP 2020 : International Conference on Cholinergic Drugs and Pharmacogenetics

Dubai, UAE
November 9 - 10, 2020

International Scientific Committee

Faris Abachi   University of Mosul, IQ
Priyanka Sabharwal   Health Partners Medical Group, US
Sivaramakrishna Yadavalli   University of Houston, US
Manju Bhaskar   National Institutes of Health, US
Ketevan Tavamaishvili   Intellewave Inc, US
Venkataswamy Sorna   University of Utah, US
Venugopal Thottempudi   University of Idaho, US
Kal Ramnarayan   Sapient Discovery, US
Gwo-Yu Chuang   National Institutes of Health, US
Marc Gillespie   St. John's University, US
Rolf Konig   University of Texas Medical Branch, US
Shashikant Srivastava   Ut Southwestern Medical Center, US
Mohan Goli   Ut Southwestern Medical Center, US
Subeena Sood   Medstar Health Research Institute, US
Tanay Kesharwani   Newlink Genetics Inc., US
Zhengwu Lu   Abbott Laboratories, US
David Stiles   Medtronic, US
Amina Ibrahim   Kumamoto University, JP
Luisetto Mauro   Ima Academy, IT
Sunil Kumar   Maharaja Agrasen University, Baddi, Solan, India, IN
Hema Gupta   Health Canada, CA
Amany Hanoun   Faculty of Medicine, Cairo University, EG
Zaniar Abas   University of Sulaimani, IQ
Alba Adriana Vallejo Cardona   The Center for Research and Assistance in Technology and Design of the State of Jalisco, MX
Rayhana Begum   Primeasia University, BD
Ashik Mosaddik   Rajshahi University, BD
Virendra Nath   Central University of Rajasthan, IN
Diana Laila Ramatillah   University August 17, 1945, ID
Rishi Saxena   Bundelkhand University, IN
Adir Glyukman   Meuhedet Health Fund, IL
Karol Wróblewski   University of Rzeszów, PL
Farzaneh Rezazadeh   Mazandaran University of Medical Sciences, IR
Chinelo Anthonia Ezeabara   Nnamdi Azikiwe University, Awka, NG
Humaira Ayub   Comsats University Islamabad, PK